Thinking commercial during drug discovery and development
When your product launches five, eight or ten years from now, what do you intend the label to read? Join Johnson & Johnson Innovation – JLABS for a dynamic symposium where experienced professionals and J&J experts explore the power of the Target Product Profile (TPP) in shaping business decisions and fostering collaboration. From target population to formulation, and benefits to payment models, our speakers will navigate the intricate landscape of drug development.
Experienced professionals and J&J experts explore :
- How do you define the exact target population, indication and formulation?
- Which benefits, risks and tolerability concerns are acceptable?
- What could be unique selling points compared to future competitors?
- What is your business model and who is going to pay, using what model?
Don’t miss out! Start-ups, early innovators and entrepreneurs are welcome to register here https://jji.jnj/briskr. We also welcome stakeholders supporting these start-ups.